Association of ACEi/ARB Use and Clinical Outcomes of COVID-19 Patients With Hypertension

Objectives: Evidence has shown that angiotensin-converting enzyme 2 (ACE2), which can be upregulated after angiotensin-converting enzyme inhibitor (ACEi) and angiotensin receptor blocker (ARB) treatment, may play a dual role in the pathogenesis and progression of coronavirus disease 2019 (COVID-19)....

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Jing, Shi, Xiaowei, Yu, Jiong, Lv, Feifei, Wu, Jian, Sheng, Xinyu, Pan, Qiaoling, Yang, Jinfeng, Cao, Hongcui, Li, Lanjuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8202940/
https://www.ncbi.nlm.nih.gov/pubmed/34136537
http://dx.doi.org/10.3389/fcvm.2021.577398

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8202940/
https://www.ncbi.nlm.nih.gov/pubmed/34136537
http://dx.doi.org/10.3389/fcvm.2021.577398

Ejemplares similares